Roy Beveridge, Humana: Interview Q&A
Q: Precision medicine will have a huge economic impact on health care. As a result, value-based versus cost-based pricing needs to be considered from a patient, pharma, and payor perspective. What are some of the challenges of implementing value-based pricing, and how...
read moreJennifer Doudna, UC Berkeley: Interview Q&A
Q: You helped make one of the most monumental discoveries in biology that allows to alter an organism's DNA. Can you tell us how this came about? What lead to the discovery? A: CRISPR-Cas9 gene editing technology is the result of a fundamental, curiosity-driven...
read moreDaniel S. Chen, Genentech: Interview Q&A
Q: Immunotherapy has rapidly evolved into a game-changing cancer treatment strategy for a wide array of different cancers, though some patients respond better than others.How important are biomarker assays for patient-selection to guide clinicians to use...
read moreBanking Your Future with BioBanks
Ever since the first human genome was sequenced, the expectation has been that biobanking would be one of the critical cornerstones that enables the revolution in the practice of medicine–precision medicine. Biobanks provide critical research and infrastructure...
read moreBig Health Data Sharing: Benefits, Challenges and Solutions
Data is King! We all agree that sharing genomic and other health data is instrumental to enable the next wave of scientific advancements which ultimately translate to better diagnoses, treatment options, and overall well-being for patients around the globe. Yet, there...
read moreWhy is patient advocacy so important? Interview Q&A with the Schorrs
PMWC Intl.: Why is patient advocacy so important? Andrew Schorr: We are in an era of Precision Medicine, but sadly, if patients don’t ask, they too often don’t receive support. Patients now need to see themselves as consumers who must play an active role in their...
read moreAris Baras, Regeneron Genetics Center: Interview Q&A
Q: What were the motivations to create the Regeneron Genetics Center? A: Human genetics is one of the most powerful approaches available in drug discovery and development today. One of the biggest bottlenecks remaining in drug discovery is the identification of...
read moreA New Presidential Administration Means Change
Attend PMWC 2017 Silicon Valley 3 days after the inauguration to hear from those in the know! How major will the changes be? Will we see a change in regulations, research funding, and drug or device approval? Will the oversight of different government initiatives...
read moreBrad Gray, Nanostring Technologies: Interview Q&A
Q: What are some of the key components of the NanostringnCounter Analysis System? What are some of the advantages of the nCounter System over other analytical approaches? A: Our nCounter Analysis System unlocks massive amounts of biological information from tiny...
read moreFred C. Tenover, Cepheid: Interview Q&A
Q: Can you share with us your motivation and interest in antimicrobial resistance and development of rapid diagnostic methods for infectious disease? And why is this so important? A: We are fast approaching a time when antibiotics will no longer work and simple...
read more
